BIOSPECIFICS TECHNOLOGIES CORP - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 14, 2016

Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - BIOSPECIFICS TECHNOLOGIES CORPex32_1.htm
EX-21.1 - EXHIBIT 21.1 - BIOSPECIFICS TECHNOLOGIES CORPex21_1.htm
EX-23.2 - EXHIBIT 23.2 - BIOSPECIFICS TECHNOLOGIES CORPex23_2.htm
EX-10.19 - EXHIBIT 10.19 - BIOSPECIFICS TECHNOLOGIES CORPex10_19.htm
EX-10.20 - EXHIBIT 10.20 - BIOSPECIFICS TECHNOLOGIES CORPex10_20.htm
EX-31.1 - EXHIBIT 31.1 - BIOSPECIFICS TECHNOLOGIES CORPex31_1.htm
10-K - BIOSPECIFICS TECHNOLOGIES CORP 10-K 12-31-2015 - BIOSPECIFICS TECHNOLOGIES CORPform10k.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement of BioSpecifics Technologies Corp. on Form S-8 (No. 333-160583) of our report dated March 14, 2016, on our audits of the consolidated financial statements as of December 31, 2015 and 2014 and for the years then ended, and the effectiveness of BioSpecifics Technologies Corp.'s internal control over financial reporting as of December 31, 2015, which reports are included in this Annual Report on Form 10-K.

/s/ EisnerAmper LLP

New York, New York
March 14, 2016
 
 

Stock widget

Investing forum

BIOSPECIFICS TECHNOLOGIES CORP Reports